ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Predicting rehabilitation outcomes following collagenase chemonucleolysis for lumbar disc herniation using psoas muscle index.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study examined whether the preoperative psoas muscle index (PMI) at the L3 level predicts 6-month recovery after chemonucleolysis for lumbar disc herniation. The primary 6-month endpoints were: (1) no or minimal pain; and (2) ≥ 75% improvement in the Oswestry Disability Index (ODI) from baseline.
methodsThis retrospective study included 209 patients (93 men and 116 women) who underwent chemonucleolysis with collagenase for lumbar disc herniation. Baseline characteristics, follow-up data, and the PMI at the L3 level were collected for all participants. Because of significant sex differences in PMI, we stratified participants into quartiles (Q1–Q4) and used generalized linear mixed models (GLMMs) to assess longitudinal changes in postoperative pain, functional disability, and mobility, as well as their interactions with PMI in men and women. Patients were further stratified based on whether they achieved an essentially pain-free status (numeric rating scale [NRS] ≤ 1) at 6-month postoperatively and whether their ODI improvement exceeded 75%. Student t tests were performed, and receiver operating characteristic (ROC) curves were constructed to evaluate the predictive accuracy of PMI and body mass index (BMI) for postoperative recovery outcomes.
resultsPMI was significantly associated with delayed postoperative recovery. Patients with low PMI showed less pain reduction and delayed functional recovery during the 6-month follow-up. Compared with the no-pain group, PMI was significantly lower in both sexes in the pain group (P < 0.001), whereas BMI was lower only in males (P < 0.05). PMI was significantly lower in both sexes in the group with ≤ 75% ODI improvement than in the group with > 75% improvement (P < 0.001). ROC curve analysis showed that PMI had high predictive accuracy for both postoperative NRS and ODI scores.
conclusionPMI was significantly associated with postoperative NRS and ODI after chemonucleolysis. Preoperative PMI assessment can help clinicians identify high-risk patients and tailor rehabilitation.
Indexed as
Identifiers
41920348What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.